DK1294369T3 - Hidtil ukendte formuleringer med alfa-2,4-disulfophenyl-N-tert-bytylnitron - Google Patents
Hidtil ukendte formuleringer med alfa-2,4-disulfophenyl-N-tert-bytylnitronInfo
- Publication number
- DK1294369T3 DK1294369T3 DK01934785T DK01934785T DK1294369T3 DK 1294369 T3 DK1294369 T3 DK 1294369T3 DK 01934785 T DK01934785 T DK 01934785T DK 01934785 T DK01934785 T DK 01934785T DK 1294369 T3 DK1294369 T3 DK 1294369T3
- Authority
- DK
- Denmark
- Prior art keywords
- disulfophenyl
- tert
- alpha
- new formulations
- butyl nitrone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0001916A SE0001916D0 (sv) | 2000-05-23 | 2000-05-23 | Novel formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1294369T3 true DK1294369T3 (da) | 2005-11-14 |
Family
ID=20279797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01934785T DK1294369T3 (da) | 2000-05-23 | 2001-05-22 | Hidtil ukendte formuleringer med alfa-2,4-disulfophenyl-N-tert-bytylnitron |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US20030181527A1 (da) |
| EP (1) | EP1294369B1 (da) |
| JP (1) | JP3744857B2 (da) |
| KR (1) | KR20030001545A (da) |
| CN (1) | CN1268326C (da) |
| AR (1) | AR030218A1 (da) |
| AT (1) | ATE303803T1 (da) |
| AU (2) | AU2001260935B2 (da) |
| BR (1) | BR0111055A (da) |
| CA (1) | CA2408781A1 (da) |
| CZ (1) | CZ20023849A3 (da) |
| DE (1) | DE60113255T2 (da) |
| DK (1) | DK1294369T3 (da) |
| EE (1) | EE200200653A (da) |
| ES (1) | ES2247112T3 (da) |
| HK (1) | HK1051649A1 (da) |
| HU (1) | HUP0302310A3 (da) |
| IL (1) | IL152533A0 (da) |
| IS (1) | IS6610A (da) |
| MX (1) | MXPA02011533A (da) |
| MY (1) | MY130445A (da) |
| NO (1) | NO20025461D0 (da) |
| NZ (1) | NZ522329A (da) |
| PL (1) | PL361284A1 (da) |
| RU (1) | RU2271800C2 (da) |
| SE (1) | SE0001916D0 (da) |
| SK (1) | SK16542002A3 (da) |
| TW (1) | TWI259078B (da) |
| WO (1) | WO2001089507A1 (da) |
| ZA (1) | ZA200208747B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050182060A1 (en) * | 2004-02-13 | 2005-08-18 | Kelly Michael G. | 2-Substituted and 4-substituted aryl nitrone compounds |
| US9265834B2 (en) | 2009-03-05 | 2016-02-23 | Ablynx N.V. | Stable formulations of polypeptides and uses thereof |
| WO2010100135A1 (en) | 2009-03-05 | 2010-09-10 | Ablynx N.V. | Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof |
| EP2470015B1 (en) * | 2009-08-24 | 2016-01-13 | Hough Ear Institute | Nitrone compounds for treating sensorineural hearing loss |
| PT2473528E (pt) * | 2009-09-03 | 2015-03-04 | Ablynx Nv | Formulações estáveis de polipéptidos e seus usos |
| US20120258926A1 (en) * | 2009-12-15 | 2012-10-11 | Valentyn Antochshuk | Formulations of acadesine |
| ES2893825T3 (es) * | 2011-02-04 | 2022-02-10 | Hough Ear Inst | Métodos de tratamiento de lesiones cerebrales |
| WO2014064717A1 (en) * | 2012-10-25 | 2014-05-01 | Fresenius Kabi Oncology Limited | Stable pharmaceutical composition of 5-αζα-2'ρεοχυοτιρινε |
| US10660851B2 (en) | 2015-01-02 | 2020-05-26 | Rxos Medical | Polyfunctional radical scavenger hydrogel formulation |
| CN116650411A (zh) * | 2022-02-25 | 2023-08-29 | 广州喜鹊医药有限公司 | 一种注射用硝酮嗪药物组合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2044829T3 (es) * | 1989-10-17 | 1995-01-16 | Oklahoma Med Res Found | Metodo y composiciones para la inhibicion de alteraciones asociadas con las lesiones oxidativas de los tejidos. |
| JP2813023B2 (ja) * | 1990-03-13 | 1998-10-22 | 株式会社神戸製鋼所 | Ｍｉｓ型ダイヤモンド電界効果トランジスタ |
| US5488145A (en) * | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
-
2000
- 2000-05-23 SE SE0001916A patent/SE0001916D0/xx unknown
-
2001
- 2001-05-09 AR ARP010102188A patent/AR030218A1/es not_active Application Discontinuation
- 2001-05-10 TW TW090111180A patent/TWI259078B/zh not_active IP Right Cessation
- 2001-05-21 MY MYPI20012391A patent/MY130445A/en unknown
- 2001-05-22 BR BR0111055-1A patent/BR0111055A/pt not_active IP Right Cessation
- 2001-05-22 EE EEP200200653A patent/EE200200653A/xx unknown
- 2001-05-22 WO PCT/SE2001/001164 patent/WO2001089507A1/en active IP Right Grant
- 2001-05-22 CA CA002408781A patent/CA2408781A1/en not_active Abandoned
- 2001-05-22 PL PL36128401A patent/PL361284A1/xx not_active Application Discontinuation
- 2001-05-22 SK SK1654-2002A patent/SK16542002A3/sk unknown
- 2001-05-22 DK DK01934785T patent/DK1294369T3/da active
- 2001-05-22 JP JP2001585752A patent/JP3744857B2/ja not_active Expired - Fee Related
- 2001-05-22 AT AT01934785T patent/ATE303803T1/de not_active IP Right Cessation
- 2001-05-22 HU HU0302310A patent/HUP0302310A3/hu unknown
- 2001-05-22 US US10/276,747 patent/US20030181527A1/en not_active Abandoned
- 2001-05-22 AU AU2001260935A patent/AU2001260935B2/en not_active Ceased
- 2001-05-22 RU RU2002129588/15A patent/RU2271800C2/ru not_active IP Right Cessation
- 2001-05-22 NZ NZ522329A patent/NZ522329A/en unknown
- 2001-05-22 CZ CZ20023849A patent/CZ20023849A3/cs unknown
- 2001-05-22 DE DE60113255T patent/DE60113255T2/de not_active Expired - Fee Related
- 2001-05-22 IL IL15253301A patent/IL152533A0/xx unknown
- 2001-05-22 CN CNB018098401A patent/CN1268326C/zh not_active Expired - Fee Related
- 2001-05-22 ES ES01934785T patent/ES2247112T3/es not_active Expired - Lifetime
- 2001-05-22 AU AU6093501A patent/AU6093501A/xx active Pending
- 2001-05-22 KR KR1020027015761A patent/KR20030001545A/ko active IP Right Grant
- 2001-05-22 EP EP01934785A patent/EP1294369B1/en not_active Expired - Lifetime
- 2001-05-22 MX MXPA02011533A patent/MXPA02011533A/es active IP Right Grant
-
2002
- 2002-10-29 ZA ZA200208747A patent/ZA200208747B/en unknown
- 2002-11-11 IS IS6610A patent/IS6610A/is unknown
- 2002-11-14 NO NO20025461A patent/NO20025461D0/no unknown
-
2003
- 2003-05-30 HK HK03103875A patent/HK1051649A1/xx not_active IP Right Cessation
-
2007
- 2007-10-12 US US11/974,504 patent/US20080161406A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20023616L (no) | Ny anvendelse | |
| NO20031483L (no) | Vaksine | |
| NO20026175L (no) | Vaksinesammensetning | |
| EE200200387A (et) | Fulvestrandi formulatsioonid | |
| NO20024170D0 (no) | Forminsket, nållös injektor | |
| NO20024172D0 (no) | Vaksine | |
| ATE391531T1 (de) | Schweisshemmende mittel | |
| ATE393614T1 (de) | Enganliegende, flüssigkeitsaustritt- widerstandsfähige damenbinde | |
| DK1294369T3 (da) | Hidtil ukendte formuleringer med alfa-2,4-disulfophenyl-N-tert-bytylnitron | |
| NO20001294D0 (no) | Måler for skyvekraft | |
| DE60133976D1 (de) | Turbomaschinen | |
| DE10196460T1 (de) | Selbstzerstör-Spritze | |
| DE60104126D1 (de) | Fungizide formulierung | |
| ATE268116T1 (de) | Mesotrion-formulierungen | |
| DE60125927D1 (de) | Impfstoffe gegen hiv | |
| DE50105857D1 (de) | Phenoxyphenyl alkansulfonate | |
| DE50114606D1 (de) | Schalungsmaterial | |
| IT249372Y1 (it) | Struttura perfezionata di gancio. | |
| IT250210Y1 (it) | Scudetto | |
| SE0004580D0 (sv) | Leveranspunkt | |
| SE0000645D0 (sv) | New pharmaceutically active compounds | |
| ITPR20000011A0 (it) | Barella | |
| DK1267849T3 (da) | Begrænsning af genoptagelse af lægemiddelanvendelse | |
| SE0001240D0 (sv) | Injektionsspruta | |
| NO20001452D0 (no) | Sprøyte |